Company
Ensoma
The future of medicine lies within us.
Also known as Ensoma, Inc
- Business model
- B2B
- Legal name
- Ensoma, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Ensoma is a biotechnology company pioneering a next-generation in vivo approach to genetically engineer bone marrow stem cells that will broaden access to curative genetic medicines
Funding snapshot
- Total raised
- $170MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Undisclosed, $53M2025-09-22
Funding rounds
- Round, 2025
- $53M2025-09-22, Company stated
- Round, 2022
- $129M2022-12-23, SEC form D sold, 22 investors
- Round, 2021
- $40.5M2021-02-05, SEC form D sold, 11 investors
Products
- Other
- EN-374
Loading relationship preview